Suppressor of cytokine signaling 2 modulates regulatory T cell activity to suppress liver hepatocellular carcinoma growth and metastasis
SOCS2 modulates CD4<sup>+</sup> T function in the TME, contributing to LIHC progression. Targeting SOCS2 presents a potential therapeutic strategy for treating LIHC.
Authors
- Shi-Chang Zhang (ORCID: https://orcid.org/0000-0002-6587-2518)
- Jun-An Ke (ORCID: https://orcid.org/0009-0009-6803-2512)
- Yiwen Zhou (ORCID: https://orcid.org/0000-0002-2794-9449)
- Rong Huang (ORCID: https://orcid.org/0000-0002-7850-6736)
- Zhao-Wen Chen
- Xiu‐Qing Li (ORCID: https://orcid.org/0000-0002-7308-0596)
- Siping Chen (ORCID: https://orcid.org/0000-0001-7953-8126)
- Xi Lan (ORCID: https://orcid.org/0000-0002-9893-3030)
- Tingting Huang (ORCID: https://orcid.org/0000-0001-5001-0782)
- Wei Wei (ORCID: https://orcid.org/0000-0002-4297-6357)
- Heng Zhang (ORCID: https://orcid.org/0000-0002-0103-2173)
- Jing Wang (ORCID: https://orcid.org/0009-0007-7824-045X)
- Xi Tang (ORCID: https://orcid.org/0009-0007-2066-8218)
Institutions
- Southern Medical University Shenzhen Hospital (CN)
Publication Details
- Journal
- World Journal of Gastroenterology
- Published
- 2025-04-02
- DOI
- https://doi.org/10.3748/wjg.v31.i13.100566
- Citations
- 1
- Primary Topic
- Cytokine Signaling Pathways and Interactions
- Type
- article
- Field-Weighted Citation Impact
- 1.05